Clobuzarit: Species differences in the morphological and biochemical response of the liver following chronic administration

This publication has 29 references indexed in Scilit:

• ANALYTICAL SUBCELLULAR FRACTIONATION AND ENZYMIC ANALYSIS OF LIVER HOMOGENATES FROM CONTROL AND CLOFIBRATE‐TREATED RATS, MICE, AND MONKEYS WITH REFERENCE TO THE FATTY ACID‐OXIDIZING ENZYMES
  Annals of the New York Academy of Sciences, 1982
• Cytochrome P-450 induction by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid)
  Biochemical Journal, 1982
• Review of the hepatic response to hypolipidaemic drugs in rodents and assessment of its toxicological significance to man
  Food and Cosmetics Toxicology, 1981
• The effects of phenobarbitone on urinary 6β-hydroxycortisol excretion and hepatic enzyme activity in the marmoset monkey (callithrix jacchus)
  Biochemical Pharmacology, 1980
• Effects of -chlorophenoxyisobutyric acid (CPIB) on the human liver
  Atherosclerosis, 1980
• Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens
  Nature, 1980
• Three Hypolipidemic Drugs Increase Hepatic Palmitoyl-Coenzyme A Oxidation in the Rat
  Science, 1977
• The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.
  British Journal of Clinical Pharmacology, 1976
• MICROBODIES IN EXPERIMENTALLY ALTERED CELLS
  The Journal of cell biology, 1967
• Changes in the weight and composition of the liver in the rat, dog and monkey treated with ethyl chlorophenoxyisobutyrate
  Biochemical Pharmacology, 1966